Yahoo Web Search

Sign In
  1. Explore more companies

Search results

  1. Regeneron Pharmaceuticals - Local Result

  2. www.regeneron.comRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

    Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.

  3. en.wikipedia.org › wiki › Regeneron_PharmaceuticalsRegeneron Pharmaceuticals - Wikipedia

    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

    • 11,851 (December 2022)
    • US$12.17 billion (2022)

  4. www.regeneron.com › globalRegeneron's Industry-Leading Biotechnology - Pushing The ...

    Regeneron is a leading biotechnology company that seeks to invent, develop and commercialize life-transforming medicines for people with serious diseases. Founded and led for 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA- or EMA-approved treatments and ...

  5. People also ask

  6. www.regeneron.com › pipeline-medicinesRegeneron Pharmaceutical's Pipeline & Medicines

    SERIOUS DISEASES. Our goal is to address serious medical conditions across multiple and diverse therapeutic areas. Our pipeline is powered by end-to-end research and development capabilities, and our commitment to operational excellence and patient safety ensures we consistently produce the highest-quality medicines.

  7. www.regeneron.com › covid19Regeneron’s COVID-19 Response Efforts

    OUR RAPID RESPONSE TO COVID-19. During the COVID-19 pandemic, Regeneron applied our more than 30 years of scientific and technology expertise to combat a novel and quickly mutating virus. We were uniquely positioned to face this public health threat given our proprietary VelociSuite® technologies and our track record against infectious ...

  8. Videos

    View all

  9. www.regeneron.com › about › historyHistory of Regeneron Pharmaceuticals: 35 Years of Innovation

    Regeneron takes full ownership of Libtayo ® (cemiplimab) injection, with exclusive worldwide development, commercialization and manufacturing rights. The FDA approved Libtayo in first-line NSCLC in combination with chemotherapy in the fourth quarter of 2022 Regeneron acquires Checkmate Pharmaceuticals, deepening its immuno-oncology portfolio

  1. Searches related to Regeneron Pharmaceuticals

    dupixent regeneron pharmaceuticalsregn stock
    regeneron pharmaceuticals stockjobs at regeneron
    sanofi and regeneron pharmaceuticalsregeneron
    regeneron pharmaceuticals careersregeneron pharmaceuticals pipeline
  2. People also search for